Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis
- PMID: 8875230
Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis
Abstract
The efficiency with which adenoviral vectors infect airway epithelial cells in vivo is unclear despite extensive preclinical and clinical studies. Our hypothesis is that gene transfer is limited by vector internalization which is mediated by binding of a fiber with a cellular receptor and the RGD motif of the penton base of the virus with cellular alpha v beta integrin. Experiments in mice demonstrate an anatomical gradient of susceptibility to adenoviral vector-mediated gene transfer with epithelia of proximal structures, such as nose and trachea, much less infectable than the distal noncartilaginous airway. Throughout the airway, gene transfer is dependent on RGD-mediated interactions which are rate limiting in the distal lung. A panel of tissues from cystic fibrosis and non-cystic fibrosis patients was analyzed for expression of alpha v beta 5 integrin which is capable of mediating RGD-dependent uptake of vector. Luminal epithelial cells of the nose and trachea were void of alpha v beta 5 expression whereas abundant expression of this integrin was present in virtually all epithelial cells of distal conducting airway. These findings could explain difficulties we and others have had in correcting the functional deficit of cystic fibrosis nasal epithelia and suggest that gene transfer efficiency may be greater in distal human lung.
Similar articles
-
Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway.J Virol. 1995 Oct;69(10):5951-8. doi: 10.1128/JVI.69.10.5951-5958.1995. J Virol. 1995. PMID: 7545239 Free PMC article.
-
A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.N Engl J Med. 1995 Sep 28;333(13):823-31. doi: 10.1056/NEJM199509283331302. N Engl J Med. 1995. PMID: 7544439 Clinical Trial.
-
Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.Hum Gene Ther. 2010 Mar;21(3):251-69. doi: 10.1089/hum.2009.056. Hum Gene Ther. 2010. PMID: 19788389
-
Integrin-Targeting Strategies for Adenovirus Gene Therapy.Viruses. 2024 May 13;16(5):770. doi: 10.3390/v16050770. Viruses. 2024. PMID: 38793651 Free PMC article. Review.
-
Advances in cystic fibrosis gene therapy.Curr Opin Pulm Med. 2004 Nov;10(6):542-6. doi: 10.1097/01.mcp.0000142102.91202.04. Curr Opin Pulm Med. 2004. PMID: 15510064 Review.
Cited by
-
Helper-Dependent Adenoviral Vectors.J Genet Syndr Gene Ther. 2011 Oct 29;Suppl 5:001. doi: 10.4172/2157-7412.s5-001. J Genet Syndr Gene Ther. 2011. PMID: 24533227 Free PMC article.
-
A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia.J Virol. 1999 Oct;73(10):8689-95. doi: 10.1128/JVI.73.10.8689-8695.1999. J Virol. 1999. PMID: 10482622 Free PMC article.
-
Adenovirus.Curr Top Microbiol Immunol. 2010;343:195-224. doi: 10.1007/82_2010_16. Curr Top Microbiol Immunol. 2010. PMID: 20376613 Free PMC article. Review.
-
Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.J Virol. 2001 Dec;75(23):11284-91. doi: 10.1128/JVI.75.23.11284-11291.2001. J Virol. 2001. PMID: 11689608 Free PMC article.
-
Interactions of soluble recombinant integrin alphav beta5 with human adenoviruses.J Virol. 1998 Nov;72(11):8669-75. doi: 10.1128/JVI.72.11.8669-8675.1998. J Virol. 1998. PMID: 9765407 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical